Strategies for Cardiac Protection in Minimally Invasive Valve Surgery (EP Video)
Dr. Philip F. Bongiorno discusses strategies for myocardial protection during minimally invasive valve surgery (27: 50 minutes).
You may also like
Postoperative Nadir Hemoglobin and Adverse Outcomes in Patients Undergoing On-Pump Cardiac Operation
Compared with the risks when nadir hemoglobin is 9.0 to 9.9 g/dL, the risk of composite adverse events increases when postoperative nadir hemoglobin is below 9.0 g/dL, whereas risk of death increases when nadir hemoglobin is below 7.0 g/dL.
1 min read
Platelet-Rich Plasma and Platelet Gel Preparation Using Plateltex(R)
Here we report the technical performance of this system in comparison with the performance of other commercially available systems: PRGF(R), PRP-Landesber, Curasan(R), PCCS(R), Harvest(R), Vivostat(R), Regen(R) and Fibrinet(R).
1 min read